View Cart (0 items)

Pharmaceutical

FDA looks into link between diabetes drugs and pancreatic cancer risk

No Comments
The U.S. Food and Drug Administration (FDA) is investigating a possible link between a number of commonly used diabetes drugs and pre-cancerous changes to the pancreas.
Read More

Bayer confident of business growth with new drugs

No Comments
German chemical and pharmaceutical giant Bayer has developed an ambitious program that aims to cement the company's position among the leading names in the global pharmaceutical industry.
Read More

Reckitt hit by FDA approval of rival drugs

No Comments
The U.S. Food and Drug Administration (FDA) has given the green light to two generic versions of Suboxone, a drug used for treating heroin addiction, manufactured by Reckitt Benckiser.
Read More

New drugs launched in UK on the rise

No Comments
Recent research by a team of scientists at Birmingham University in central England has dismissed fears that British patients might have to cope with a shortage of drugs.
Read More

Merck to pay $8.5 million to settle Vioxx case in Pennsylvania

No Comments
New Jersey-based pharmaceutical giant Merck & Co. has agreed to pay $8.5 million to the state of Pennsylvania to settle allegations that it inappropriately marketed its painkiller Vioxx.
Read More

Engineer suffers chemical burns at GlaxoSmithKline plant

No Comments
A 20-year-old engineer suffered chemical burns Tuesday in an industrial accident at a GlaxoSmithKline (GSK) plant.
Read More

Asia offers big business opportunities to pharma companies

No Comments
Asia is emerging as a strategically important location for global pharmaceutical companies that are looking to take advantage of the opportunities available in terms of R&D, manufacturing and market.
Read More

Pharm industry sales to top $1.2 trillion by 2016

Globalization impacts demand and production of pharmaceuticals
No Comments
Pharmaceutical manufacturers today face a considerable checklist of significant challenges, including the fight against counterfeiting, reducing costs through offshore manufacturing and maintaining product integrity.
Read More

Pharma companies set high hopes for 2013

No Comments
Following the approval of 39 new drugs in 2012, and with a number of new pharmaceutical products already in their final stages of development, global pharma companies are optimistic about the next 12 months.
Read More

FDA to tighten control on painkillers

No Comments
The U.S. Food and Drug Administration (FDA) is considering measures to make prescription drugs more difficult to access in a move to prevent overdoses associated with painkillers like OxyContin and Opana, which killed 16,000 people in 2010 alone.
Read More